Faih.Ns

FAIH.NS has a debt-to-equity ratio of 0.21 and a current ratio of 2.3, indicating a relatively strong liquidity position with sufficient current assets to cover current liabilities. However, the company reported negative operating cash flow of -167.79 million INR and negative free cash flow of -33.66 million INR, suggesting challenges in generating positive cash from operations. The company's capital expenditure of -261.09 million INR indicates significant investment in long-term assets, which may be a strategic move to expand or modernize its operations.

In terms of profitability, FAIH.NS reported a return on equity (ROE) of 7.28% and a return on assets (ROA) of 5.47%. These figures are to be compared against the industry's preferred metrics, which typically emphasize ROE and ROA as key indicators of financial performance. The company's ROE and ROA are in line with the industry's expectations, but the exact cohort medians are not provided for a direct comparison.

The company's revenue is concentrated in a single business segment, as no specific segments are disclosed in the available data. There is no detailed geographic breakdown provided, but the company's operations are likely centered in India, given the currency and market context. The lack of segment and geographic diversification may expose the company to higher concentration risk, particularly in volatile markets.

Looking at the growth trajectory, the company's revenue for the latest period is 5,378.98 million INR. While the outlook for the current and next fiscal years is not explicitly provided, the company's capital expenditure and investment in long-term assets suggest a strategic focus on growth and expansion. The negative operating and free cash flows, however, may indicate short-term financial pressures that could affect the company's ability to sustain growth.

The risk assessment for FAIH.NS indicates a medium liquidity risk and a low dilution risk. The company's net cash is negative after subtracting total debt, which could affect its ability to meet short-term obligations without additional financing. The dilution risk is low, suggesting that the company is not expected to issue a significant number of new shares in the near term. The adjustments applied in the valuation do not indicate any major issues with the company's financial health.

Recent events and filings do not provide specific details on the company's strategic moves or financial decisions. The company's financial statements and disclosures are consistent with its classification as a specialty chemicals firm, but there are no notable recent developments that would significantly alter the company's risk profile or growth prospects.